Covered recipient · General Payments record
KATHRYN SCORE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2025
$879.44
- Reported across 46 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $279.63 | 16 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $86.29 | 5 |
| Amgen Inc. | $33.82 | 2 |
| Organon LLC | $30.64 | 2 |
| Hologic Sales and Service, LLC | $24.74 | 1 |
| Lilly USA, LLC | $20.23 | 1 |
| Sumitomo Pharma America, Inc. | $18.97 | 1 |
| Pelvital USA, Inc. | $17.53 | 1 |
| Novo Nordisk AS | $16.89 | 1 |
| PFIZER INC. | $15.39 | 1 |
| DEXCOM, INC. | $15.13 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $18.52 | 03/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228629558 | CMS |
| Amgen Inc. | $15.30 | 12/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228629560 | CMS |
| Astellas Pharma US Inc | $16.95 | 01/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238704966 | CMS |
| Astellas Pharma US Inc | $17.02 | 04/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238706768 | CMS |
| Astellas Pharma US Inc | $16.20 | 06/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238635212 | CMS |
| Astellas Pharma US Inc | $16.66 | 07/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238635804 | CMS |
| Astellas Pharma US Inc | $19.46 | 08/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238635340 | CMS |
| Dexcom, Inc. | $15.13 | 08/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250499004 | CMS |
| Hologic Sales and Service, LLC | $24.74 | 06/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1182526069 | CMS |
| Lilly USA, LLC | $20.23 | 08/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186705819 | CMS |
| Novo Nordisk Inc | $16.89 | 06/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188669420 | CMS |
| Organon LLC | $15.69 | 06/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237649254 | CMS |
| Organon LLC | $14.95 | 11/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237649252 | CMS |
| Pelvital USA, Inc. | $17.53 | 05/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1254990175 | CMS |
| PFIZER INC. | $15.39 | 06/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230111522 | CMS |
| Sumitomo Pharma America, Inc. | $18.97 | 04/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1176717713 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.